-
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
on behalf of the T2B! immunity against SARS-CoV-2 study group, 1 Dec 2023, In: BMC Infectious Diseases. 23, 1, 332.Research output: Contribution to journal › Article › Academic › peer-review
-
SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis
T2B! immunity against SARS-CoV-2 study group, 1 Apr 2023, In: Journal of neurology, neurosurgery, and psychiatry. 94, 4, p. 280-283 4 p., jnnp-2022-330100.Research output: Contribution to journal › Article › Academic › peer-review
-
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
the T2B! immunity against SARS-CoV-2 study group, 1 Feb 2023, In: Journal of autoimmunity. 135, 102984.Research output: Contribution to journal › Article › Academic › peer-review
- All publications